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Background:  The prevalence of sleep-disordered breathing (SDB) in patients with heart failure (HF) is high, and SDB is increasingly being 
recognised as contributing to morbidity and mortality in these patients. This prospective study investigated the prevalence of SDB and its 
predictors in patients with stable chronic HF.
methods:  The ongoing German multicentre SchlaHF registry (NCT01500759) provides demographic and clinical data on stable chronic 
HF patients. Inclusion criteria were chronic, stable, symptomatic HF (New York Heart Association [NYHA] class ≥II) and left ventricular 
ejection fraction (LVEF) ≤45%. All patients were receiving optimized medical therapy for HF. SDB (apnea-hypopnea index ≥15/h), was 
determined using a two-channel screening device (ApneaLink, ResMed).
results:  Data on 6876 patients were analyzed. Chronic HF patients with SDB had more severe HF (higher NYHA class, higher prevalence 
of atrial fibrillation). The overall prevalence of SDB was 46%, with a significant gender difference; 36% in women (n=1448) vs 49% in 
men (n=5428). SDB prevalence increased with age (31%, 39%, 45%, 52% and 59% in those aged ≤50, >50-60, >60-70, >70-80 and >80 
years, respectively). Significant independent risk factors for SDB were body mass index (per 5 units; odds ratio [OR] 1.29, 95% confidence 
interval [CI] 1.22, 1.36), LVEF (per 5% decrement from 45%; OR 1.10, 95% CI 1.06, 1.39), age (per 10-year difference to 60 years; OR 
1.41, 95% CI 1.34-1.49), atrial fibrillation (OR 1.19, 95% CI 1.06-1.34), and male gender (OR 1.90, 95% CI 1.67-2.17).
conclusion:  SchlaHF registry data confirm the high prevalence of SDB in stable chronic HF patients. Male gender, age, body mass index 
and the severity of both symptoms and left ventricular dysfunction were clinical predictors for SDB. These results, and the fact that chronic 
HF patients with SDB often do not show characteristic SDB symptoms, suggest that the presence of one or more predictors of SDB (e.g. 
male gender, older age, obesity, LVEF <25%, NYHA class III/IV or atrial fibrillation) should prompt clinicians to perform device-based 
screening for SDB.
